8 Reasons you need Glucommander for glycemic management

From higher readmission rates to increased patient risk, hospitals nationwide are experiencing the impact of poor glycemic management—but it doesn’t need to be that way.

Leading healthcare systems across the country are adopting Glucommander. Here’s why:

Insulin therapy is becoming more critical

49.3% of U.S. adults have diabetes or prediabetes and 38% of inpatients (with or without diabetes) require insulin therapy during their stay. These numbers are on an incline.

Hospitals using Glucommander see a 99.8% reduction in severe hypoglycemia and an average length of stay reduction of 3.2 days.

Glycemic management issues lead to higher readmission rates and length of stay

Hospitals using Glucommander experienced 3.2 days reduction in average length of stay and 36-68% reduction in 30-day readmissions for AMI, CHF and CABG patients.

New CMS quality measures incentivize better glycemic control

CMS is tightening measures on how hospitals manage glycemia. Glucommander can help get patients into target blood glucose range faster—and stay there.

Patients experiencing hypoglycemia cost more to treat

The average cost of patients with hypoglycemia is $5,000-$10,000 higher than those with normal glycemia. Glucommander can save hospitals millions per year by reducing cost of care.

Paper-based insulin dosing is prone to errors and inefficiency

Glucommander can be integrated with EHR systems to automatically import data, speed up workflows and reduce errors.

Sliding scale insulin therapy is outdated and ineffective

According to the American Diabetes Association in 2020, “Use of only a sliding scale inulin regimen in the inpatient hospital setting is strongly discouraged.” Glucommander helps drive the adoption of basal-bolus insulin therapy among clinicians.

More than half of hospitals cannot analyze glucometrics

Over half of hospitals lack the ability to analyze glucose data, but Glucommander can provide advanced analytics of glycemic management performance to help set goals and expectations for improvement.

Patient outcomes can be improved with real-time surveillance

When integrated with laboratory information systems, Glucommander can provide automatic alerts to ensure proactive treatment for at-risk patients

References: 

  1. Centers for Disease Control and Prevention. National Diabetes Statistics Report website. https://www.cdc.gov/diabetes/data/statistics-report/index.html. Accessed July 25, 2022.
  2. Guillermo E. Umpierrez, Scott D. Isaacs, Niloofar Bazargan, Xiangdong You, Leonard M. Thaler, Abbas E. Kitabchi, Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes, The Journal of Clinical Endocrinology & Metabolism, Volume 87, Issue 3, 1 March 2002, Pages 978–982, https://doi.org/10.1210/jcem.87.3.8341
  3. Newsom R, Patty C, Camarena E, et al. Safely Converting an Entire Academic Medical Center From Sliding Scale to Basal Bolus Insulin via Implementation of the eGlycemic Management System. J Diabetes Sci Technol. 2018;12(1):53-59. doi:10.1177/1932296817747619
  4. Mumpower A, Hou S, McFarland R. Relationship Between Glycemic Control Using eGMS and Readmission Rates in Cardiovascular Patients Hospitalized with AMI, CHF or Undergoing CABG During the Implementation of a System Wide Glycemic Initiative. Poster Presentation at the 2016 Diabetes Technology Meeting. November 10-12, 2016.
  5. CMS. Hospital Harm – Severe Hypoglycemia (eCQM). Centers for Medicare & Medicaid Services. Updated 08-02-2021.
  6. Rabinovich, M., Grahl, J., Durr, E., Gayed, R., Chester, K., McFarland, R., & McLean, B. (2018). Risk of Hypoglycemia During Insulin Infusion Directed by Paper Protocol Versus Electronic Glycemic Management System in Critically Ill Patients at a Large Academic Medical Center. Journal of Diabetes Science and Technology, 12(1), 47–52. https://doi.org/10.1177/1932296817747617
  7. Gaines M, Pratley R, Tanton D. Financial Implications of Poor Glycemic Management & Improvement Strategies for Optimal Outcomes. IHI National Forum on Quality Improvement in Health Care. 2018.
  8. 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2020. American Diabetes Association. Diabetes Care Jan 2020, 43 (Supplement 1) S193-S202; DOI: 10.2337/dc20-S015
  9. Cook CB, Elias B, Kongable GL, Potter DJ, Shepherd KM, McMahon D. Diabetes and hyperglycemia quality improvement efforts in hospitals in the United States: current status and barriers to implementation. Endocr Pract. 2010;16(2):219–230.

See how Glucommander can transform your hospital’s glycemic management

Experience Glytec

   

©2026 Glytec, LLC

Terms of Use       Legal Disclaimer       Privacy Policy       Contraindications, Warnings and Precautions

The eGlycemic Management System® is a modularized solution for glycemic management across the care continuum that includes Glucommander®. Glucommander® is a prescription-only software medical device for glycemic management intended to evaluate current as well as cumulative patient blood glucose values coupled with patient information including age, weight and height, and, based on the aggregate of these measurement parameters, whether one or many, recommend an IV dosage of insulin, glucose or saline or a subcutaneous basal and bolus insulin dosing recommendation to adjust and maintain the blood glucose level towards a configurable physician- determined target range. Glucommander® is indicated for use in adult and pediatric (ages 2-17 years) patients. The measurements and calculations generated are intended to be used by qualified and trained medical personnel in evaluating patient conditions in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional’s clinical judgement. No medical decision should be based solely on the recommended guidance provided by this software program. Glucommander® is only available for use in the United States. This site is only intended for use in the United States.